Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-019359
Filing Date
2019-04-11
Accepted
2019-04-11 19:06:13
Documents
1
Period of Report
2019-04-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv518749_4.html 4  
1 OWNERSHIP DOCUMENT tv518749_4.xml 4 3904
  Complete submission text file 0001144204-19-019359.txt   5626
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCO CAPITAL PARTNERS LLC 1285 AVENUE OF THE AMERICAS 85TH FLOOR NEW YORK NY 10019
Business Address
Rouhandeh Steven H (Reporting) CIK: 0001294343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 19744698